Your session is about to expire
← Back to Search
Other
Clinical and Histological Evaluation of BTL-785F Device for Non-invasive Treatment of Face
N/A
Waitlist Available
Research Sponsored by BTL Industries Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a non-surgical device to reduce facial wrinkles. It targets people with facial wrinkles and works by using energy to boost skin proteins for smoother skin.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Histological examination
Secondary study objectives
Evaluation of Overall Facial Appearance According to GAIS
Evaluation of Wrinkle Severity
Subject Satisfaction
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Subjects will be enrolled for an active treatment with BTL-785F device (BTL-785-7 applicator) for non-invasive facial rejuvenation.
Group II: ControlActive Control1 Intervention
One subject will serve as a control.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7
2022
N/A
~180
Find a Location
Who is running the clinical trial?
BTL Industries Ltd.Lead Sponsor
54 Previous Clinical Trials
1,865 Total Patients Enrolled
13 Trials studying Wrinkles
371 Patients Enrolled for Wrinkles